Editorial: Helicobacter pylori infection and antibiotic resistance: clinical, translational and experimental studies
Frontiers in Cellular and Infection Microbiology · 2023
DOI: 10.3389/fcimb.2023.1296784 ↗Kurz gefasst
Editorial in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Abbas Yadegar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical …. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori, Gastritis. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Helicobacter pylori (H. pylori) is a Gram-negative recalcitrant oncomicrobe that infects over half of the world's population. Infection with H. pylori is the primary cause of gastric and duodenal ulcers and gastric malignancies (1). Current guidelines suggest the test-and-treat strategy, which is the antibiotic-based eradication of H. pylori upon diagnosis (2). However, the development of antibiotic resistance mechanisms and the subsequent emergence of singledrug and multi-drug resistant H. pylori strains have made the achievement of successful eradication extremely challenging (3). Therefore, monitoring antibiotic resistance, elucidating resistance mechanisms and developing innovative treatment approaches have become of significant interest in this field of study. In this regard, the Research Topic of "Helicobacter pylori infection and antibiotic resistance: clinical, translational and experimental studies" appeared highly topical, presenting novel insights on the critical challenge of H. pylori Furthermore, the probiotic group presented an elevation in general health-related quality of life.In conclusion, the published studies in this Research Topic discussed the significant importance of H. pylori antibiotic resistance and its remarkable impact on the host gastric microbial structure. These studies further elaborated the potential for microbiome-based therapeutics in improving H. pylori treatment and health-related quality of life. Nevertheless, antibiotic resistance mechanisms of H. pylori are yet to be fully elucidated and require further in-depth investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Clinical Medicine, School of Medicine, Trinity College Dublin, Dublin, Ireland.
Zitieren
APA
Yadegar, A., Nabavi-Rad, A., & Smith, S. M. (2023). Editorial: Helicobacter pylori infection and antibiotic resistance: clinical, translational and experimental studies. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1296784
Vancouver
Yadegar A, Nabavi-Rad A, Smith SM. Editorial: Helicobacter pylori infection and antibiotic resistance: clinical, translational and experimental studies. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1296784
BibTeX
@article{Yadegar2023,
author = {Yadegar, Abbas and Nabavi-Rad, Ali and Smith, Sinéad Marian},
title = {Editorial: Helicobacter pylori infection and antibiotic resistance: clinical, translational and experimental studies},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
doi = {10.3389/fcimb.2023.1296784}
}
EUVIMED